 |
| APRIL
30, 2025 |
| Covering
Life Sciences Drugs, Diagnostics, Devices,
Digital Health |
|
|
|
* may need subscription to view |
 |
| Boston's
most flexible contract vivarium
lab space: Start with a few study
cages and grow. |
|
Learn More
→ |
|
|
- Alcresta Therapeutics: Enrollment of First
Patient in Clinical Trial Evaluating Use of
RELiZORB in Pancreatitis Patients at
Massachusetts General Hospital More
- Amylyx Pharmaceuticals: First Participant
Dosed in Pivotal Phase 3 LUCIDITY Trial of
Avexitide in Post-Bariatric Hypoglycemia More
- Charles River: Inaugural Advanced
Therapy Incubator Program Cohort More
- Domain Therapeutics: Presents Novel Data
Addressing Key Challenges in Oncology at AACR
2025 More
- Elpis Biopharmaceuticals: Will Present Two
"Late-Breaking" Posters Detailing Its
Pioneering CAR-T Cell Therapy Technologies at
AACR Annual Meeting 2025 More
- EveryONE Medicines and Mendelian: Partner to
Transform UK Landscape for Rare Disease
Diagnosis and Personalized Treatment More
- Flagship Pioneering: Appoints Rahul
Kakkar as CEO-Partner and CEO of Quotient
Therapeutics More
- Granata Bio: Expands Women's Health
Portfolio With Acquisition of US-Based Oviva
Therapeutics More
- GreenLight Biosciences: Breakthrough in RNA
Herbicide Development, Advancing More
Sustainable Weed Control More
- Marengo: Presents Expanded Clinical
Monotherapy Activity of Invikafusp Alfa in
Multiple PD-1 Resistant Tumors as a Clinical
Plenary Oral at AACR 2025 More
- Myomo: Launches the MyoPro 2x More
- 908 Devices: Equips rescEU Disaster
Preparedness Reserve With Advanced Chemical
Detection More
- Nuvalent: Publication in Molecular Cancer
Therapeutics Reinforcing Rational Molecular
Design of Zidesamtinib as a Novel
ROS1-Selective Inhibitor More
- Paragonix: New Study Reports Increased
4-Year Survival in Heart Transplant Patients
When Utilizing the SherpaPak System More
- Predicta Biosciences: Launches its First
Molecular Diagnostic Product to Improve the
Prognosis of Multiple Myeloma More
- Q32 Bio: FDA Fast Track Designation Granted
to Bempikibart (ADX-914) for the Treatment of
Alopecia Areata More
- Scipher Medicine and InnoSIGN: Partnership
to Advance Precision Medicine in Immunology More
- SOTIO: Promising Preclinical Data on
Antibody-Drug Conjugates SOT109 and SOT106,
Underscoring Best-in-Class Potential for Solid
Tumor Treatments More
- Unravel Biosciences: Submission of RVL-001
Clinical Study Applications for Rett Syndrome
and Pitt Hopkins Syndrome to Colombian Health
Regulatory Authority More
|
|
 |
Strategic
CFO Services for Scaling Biotech
Startups
Explore how biotech startups can
leverage fractional CFO services
to scale efficiently |
|
Learn More
→ |
|
|
- Entrada Lays Off 20% of Staff Weeks After
Having FDA Hold Lifted More
- More on Acquisition Price for Marlborough
Biotech Being Slashed More*
- More on Octagon Winding Down After
Deprioritizing Lead Program More
- Ono Pharma Lays Off 83 Staffers at
Cambridge, Massachusetts, Site More
More
More*
- Sage Therapeutics: First Quarter 2025
Financial Results and Highlights Pipeline and
Business Updates More
- Takeda: Awards $13.8 Million to U.S.
Nonprofit Partners to Promote Healthy Eating
and Expand STEM Education More
|
|
|
- Commentary: Mass. Biotechs Need to Know
Their Patents Are Secure More*
- Harvard: Bile Imbalance Linked to Liver
Cancer More
- Harvard: FDA-Approved Smoking Cessation Pill
Helps Break Vaping Habit More
- More on FDA Misses PDUFA Date for Stealth’s
Ultra-Rare Disease Candidate, Delaying
Approval Decision—Again More
- Subscribe to LifeSci Startup for
Updates on US Startups More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: Boston Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
Feature your company |
|
Apply to have your company
highlighted on our
website. |
|
|
|
|
|
|
NOTE: EVENTS AND JOBS ARE FROM
ALL BIG4BIO REGIONS
 |
|
Premier Executive Search and
Talent Advisory Firm Slone
Partners Launches Fractional
Talent Service to Deliver
On-Demand Leaders and Specialists
|
|
Learn More
→ |
|
|
- OPPORTUNITY: Chief Executive Officer More
- OPPORTUNITY: Chief Product Officer More
- OPPORTUNITY: Vice President, Digital Health
Business Development More
- OPPORTUNITY: Chief Business Officer More
- OPPORTUNITY: Vice President, Finance More
- OPPORTUNITY: Director, Compliance &
Quality Systems More
- OPPORTUNITY: West Coast Business Development
Director More
- OPPORTUNITY: Chief Financial Officer More
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Boston,
all rights reserved 2025
© 2025
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
